User:University of Washington/8 July 2008

From 2008.igem.org

(Difference between revisions)
(RP4 Conjugation)
Line 16: Line 16:
·Testing DH5α and S17-1+RP4 resistance to Chloremphenicol and Ampicillin.<br\>
·Testing DH5α and S17-1+RP4 resistance to Chloremphenicol and Ampicillin.<br\>
-
·Testing S17-1 to DH5α conjugation using RP4 plasmid.
+
·Testing S17-1 to DH5α conjugation using RP4 plasmid and conjugation protocol #1.
·Make glycerol stock of S17-1+RP4
·Make glycerol stock of S17-1+RP4

Revision as of 21:50, 8 July 2008

Contents

BioBrick Promoter Construct Sequencing

- Because the previous forward sequencing reaction and analysis yielded high-noise results, the forward sequencing protocol was carried out a second time.

- VF2 primer (100pmol/uL) was diluted 1 to 100 with distilled water.

- 8 uL of diluted VF2 primer (1pmol/uL) was added to four Eppendorf tubes.

- 4 uL of miniprepped plasmid DNA for parts I20260, I20268, I20269, and I20270 were added to tubes of primer, after appropriate labeling of the tubes.

- Plasmid template and VF2 primer solutions were resubmitted to the UW DNA Sequencing Facility for reaction and analysis.

- The index and middle fingers were crossed.

RP4 Conjugation

·Testing DH5α and S17-1+RP4 resistance to Chloremphenicol and Ampicillin.
·Testing S17-1 to DH5α conjugation using RP4 plasmid and conjugation protocol #1.

·Make glycerol stock of S17-1+RP4 UW Glycerol Stocks

Non-RP4 Conjugation

·Plate out CV13(Yep13) and pDPT51

LuxR from pLac

- Made glycerol stocks of R0010 and I763004.

- Miniprepped and sent in for sequencing part I763004.


Back to Team:University_of_Washington/Notebook#Notebook